GPC1 and pancreatic neoplasm: While GPC1 was unable to discern pancreatic cancer from BPD, nFC technology opens up the possibility of the re-examining previously-identified pancreatic cancer markers in novel combinations to develop an effective early detection test for pancreatic cancer.